Today: 15 May 2026
Bradesco Stock Is Sliding Despite a Profit Beat — Credit Risk Is Why
15 May 2026
2 mins read

Bradesco Stock Is Sliding Despite a Profit Beat — Credit Risk Is Why

SAO PAULO, May 15, 2026, 14:03 BRT

• Banco Bradesco shares trading in New York slipped $0.115 to $3.455 on Friday.
• Recurring profit for the first quarter came in at R$6.81 billion, though credit provisions also moved higher.
• Sentiment around Brazilian banks tightened after Banco do Brasil, the state lender, reported a 54% plunge in profit and trimmed its 2026 outlook.

Shares of Banco Bradesco S.A. slipped on Friday, despite a second straight quarter of profit growth from Brazil’s number-two private lender. Investors focused on rising credit costs and renewed strains hitting the country’s banking sector. The U.S.-listed American depositary shares changed hands at $3.455, a drop of $0.115 from Thursday’s close.

Timing is critical here. Bradesco is pushing to show its turnaround story holds up even as Brazil’s interest rates remain high—Selic sits at 14.50%, trimmed only slightly after a pair of quarter-point cuts. The central bank, weighing external risks and inflation, kept future policy moves undecided.

The broader market isn’t cutting much slack. Banco do Brasil delivered a 54% plunge in first-quarter adjusted net profit, according to Reuters, and trimmed its 2026 guidance. Political jitters—this week’s headlines around the collapsed Banco Master and presidential contender Flavio Bolsonaro—haven’t helped sentiment in Brazilian markets.

Bradesco turned in numbers that didn’t look soft at first glance. Recurring net income—profit minus one-offs—landed at R$6.81 billion, a 16.1% jump over the same period last year. Total revenue improved by 14.0% to R$36.88 billion. Net interest income, that crucial gap between lending earnings and funding costs, advanced 16.4%.

But on the expense side, things looked worse. Expanded loan-loss provisions—funds reserved for potentially bad loans—jumped 26.5% from a year ago, reaching R$9.67 billion. Loans overdue by more than 90 days ticked up too, now at 4.2%, compared with 4.1% in the same period last year.

Chief Executive Marcelo Noronha told investors Bradesco has taken on a “more conservative stance,” though he stressed this doesn’t signal the bank is scaling back loan growth. He flagged a particular wholesale exposure along with aging rural-credit portfolios as the main reasons behind the uptick in risk cost. MarketScreener

The gulf between the two banks isn’t shrinking. According to Jefferies figures shared by Investing.com, Bradesco delivered just 26% of Itaú Unibanco’s banking profits—way down from the roughly 80% slice it held in the first quarter of 2022. Jefferies also pegged Bradesco’s adjusted pre-tax return on risk-weighted assets at about 1.4%, falling short of Itaú’s 4% and Santander Brasil’s 2.4%.

There’s still a cushion from rate-cut optimism. On Polymarket, traders are betting with a 75.5% implied chance the central bank cuts the Selic in June; the probability for staying put sits close to 25.1%. For lenders, a rate cut could bring some relief to borrowers and potentially boost credit appetite. The risk? Lending spreads might shrink if funding costs don’t drop in tandem.

“Monetary policy remains quite restrictive,” Banco Inter chief economist Rafaela Vitoria said to Reuters after the latest rate cuts. For Bradesco, the dilemma is clear: the lender needs to grow its loan book, but not if it risks undoing two years of hard work cleaning up asset quality. Reuters

Insurance made a difference for the quarter. Income from Bradesco’s insurance, pension, and capitalization operations climbed 20.4% year-over-year. The insurance division delivered R$2.8 billion in recurring net income. Noronha pointed to Bradsaúde, the healthcare consolidation effort, as a strategic decision for capital and shareholder value.

There’s a risk here: credit jitters might not stay contained. Should rural loans, small-business working capital, or even big corporate exposures slip further, Bradesco could see provisions start to bite into the net interest income it’s banking on. And if rate cuts stall or political tensions flare up—weakening the real and stoking inflation—that outlook gets tougher.

Bradesco’s profit has bounced back for now. But investors are still looking for firmer evidence that the gains can hold up, and not just get wiped out by rising loan losses.

Stock Market Today

  • IonQ Stock Drops 7.4% Amid Market Sell-Off on Inflation and Geopolitical Concerns
    May 15, 2026, 3:59 PM EDT. IonQ shares fell 7.4% on Friday, lagging the S&P 500 and Nasdaq which dipped 0.7%. The quantum computing firm's stock is down without specific company news, as investors pull back from speculative tech amid rising inflation and geopolitical tensions, notably U.S.-China relations and supply chain issues tied to the Iran conflict. IonQ's near-term valuation remains volatile, linked closely to broader market risk appetite. Its longer-term prospects hinge on technological breakthroughs in quantum computing, positioning the stock as a high-risk, high-reward investment.

Latest articles

AT&T, Verizon, T-Mobile Rally Against Dead Zones With Uncommon Satellite Move, Eye Starlink Push

AT&T, Verizon, T-Mobile Rally Against Dead Zones With Uncommon Satellite Move, Eye Starlink Push

15 May 2026
AT&T, Verizon, and T-Mobile announced plans to jointly build a satellite-based network to eliminate U.S. wireless dead zones, aiming to connect ordinary phones directly to satellites. The move follows the FCC’s approval of EchoStar’s $40 billion spectrum sale to SpaceX and AT&T. The carriers have an agreement in principle but have not finalized terms. AT&T reported $31.5 billion in Q1 revenue and $126.4 billion in net debt.
UBS Calls Time on Ambev’s Run After Brazil Beer Surge

UBS Calls Time on Ambev’s Run After Brazil Beer Surge

15 May 2026
Ambev’s São Paulo shares fell 0.25% to 15.73 reais Friday, despite UBS raising its target price but maintaining a Sell rating. First-quarter profit rose 2.1% to 3.89 billion reais, with Brazil Beer volumes hitting a record and net revenue up 9.6%. Cash flow surged 162.5% to 3.16 billion reais. Consolidated cash cost of goods sold per hectoliter climbed 8.5%.
Pfizer Inc Looks to India for Growth—But Proof Remains Elusive for Investors

Pfizer Inc Looks to India for Growth—But Proof Remains Elusive for Investors

15 May 2026
Pfizer is increasing investment in India for cancer drugs, obesity treatments, and vaccines as it seeks growth beyond COVID-era sales. The company reported Q1 revenue of $14.5 billion, up 5%, but expects a $1.5 billion hit this year from generic competition. Shares fell 1.8% to $25.29 in New York trading. In Europe, Pfizer won expanded approval for its hemophilia drug Hympavzi.
Shares of BigBear.ai Slide as Defense AI Hype Wavers

Shares of BigBear.ai Slide as Defense AI Hype Wavers

15 May 2026
BigBear.ai shares fell about 5% to $4.16 Friday afternoon after reporting flat first-quarter revenue of $34.4 million and a wider adjusted EBITDA loss of $9.9 million. Backlog rose 14% to $281.9 million, boosted by a $53 million classified contract. The company kept its 2026 revenue forecast at $135 million to $165 million. Gross margin improved to 34.0% from 21.3% a year earlier.
Amazon Stock Slips As Alexa’s AI Shopping Push Moves From Search To Checkout
Previous Story

Amazon Stock Slips As Alexa’s AI Shopping Push Moves From Search To Checkout

MARA Holdings Stock Falls as Bitcoin Slide Tests Its $1.5 Billion AI Power Bet
Next Story

MARA Holdings Stock Falls as Bitcoin Slide Tests Its $1.5 Billion AI Power Bet

Go toTop